| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
See Remarks | Chief Operations Officer
1 company
Raquel E. Izumi last filed a Form 4 in August 2024, as See Remarks at VINC. Raquel E. Izumi's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
At the last filing, the largest reported position was 85,214 shares of VINC. Net of sales, the VINC filings show accumulation of 86,214 shares.
Raquel E. Izumi has 12 Form 4 filings on record from December 2020 to August 2024, all as Vincerx Pharma (VINC), 2020–2024.
The 24 reported transactions were 12 option or other derivative awards, 6 dispositions back to the company, 5 open-market purchases and 1 stock award.
Counted by filing, the open-market trades come to 4 purchases worth about $109K and no sales.
The largest open-market purchase was 40,000 shares of VINC at an average $1.41 on June 27, 2022, about $56K.
Shares as reported in the last Form 4 for each company; the most recent is from August 2024. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | VINC Vincerx Pharma, Inc. | See Remarks | Buy | 16,476 | $0.91 | $14,934.21 | +24.0% | |
| Dec 14, 2022 | VINC Vincerx Pharma, Inc. | See Remarks | Buy | 28,738 | $0.88 | $25,427.38 | +71.8% | |
| Jun 27, 2022 | VINC Vincerx Pharma, Inc. | See Remarks | Buy | 40,000 | $1.41 | $56,312.00 | New | |
| Aug 4, 2021 | VINC Vincerx Pharma, Inc. | See Remarks | Buy | 1,000 | $11.96 | $11,960.00 | New |